Creatine supplementation prevents the inhibition of myogenic differentiation in oxidatively injured C2C12 murine myoblasts

Molecular Nutrition and Food Research

Volumn 53, Issue 9, 2009, Pages 1187-1204

  Sestili, Piero ^a   Barbieri, Elena ^a   Martinelli, Chiara ^a   Battistelli, Michela ^b   Guescini, Michele ^a   Vallorani, Luciana ^a   Casadei, Lucia ^a   D'Emilio, Alessandra ^a   Falcieri, Elisabetta ^a,c   Piccoli, Giovanni ^a   Agostini, Deborah ^a   Annibalini, Giosué ^a   Paolillo, Marco ^a   Gioacchini, Anna Maria ^a   Stocchi, Vilberto ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b Laboratorio di Biologia Cellulare e Microscopia Elettronica   (Italy)

^c CNR   (Italy)

Author keywords

Antioxidants; Creatine; Myogenesis; Nutritional supplements; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CATALASE; CREATINE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MESSENGER RNA; SOMATOMEDIN C;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOLOGY; DIET SUPPLEMENTATION; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; MYOBLAST; OXIDATION REDUCTION REACTION; PROTEOMICS; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; CATALASE; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CREATINE; DIETARY SUPPLEMENTS; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INSULIN-LIKE GROWTH FACTOR I; MICE; MYOBLASTS; OXIDATION-REDUCTION; PROTEOMICS; RNA, MESSENGER;

MAMMALIA; MURINAE;

EID: 70349636311     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800504     Document Type: Article

References (83)

1. Charge, S. B., Rudnicki, M. A., Cellular and molecular regulation of muscle regeneration, Physiol. Rev. 2004, 84, 209-238.
2. Collins, C. A., Olsen, I., Zammit, P. S., Heslop, L., et al.,Stem cell function, self-renewal, and behavioral heterogene-ity of cells from the adult muscle satellite cell niche, Cell 2005,122,289-301.
3. Mauro, A., Satellite cell of skeletal muscle fibers, J. Biophys. Biochem. Cytol. 1961, 9, 493-495.
4. [4] Holterman, C. E., Rudnicki, M. A., Molecular regulation of satellite cell function, Semin. Cell. Dev. Biol. 2005, 16, 575- 584.
5. Partridge, T. A., Grounds, M., Sloper, J. C., Evidence of fusion between host and donor myoblasts in skeletal muscle grafts, Nature 1978, 273, 306-308.
6. Burattini, S., Ferri, P., Battistelli, M., Curci, R., et al., C2C12 murine myoblasts as a model of skeletal muscle development: Morpho-functional characterization, Eur. J. Histochem. 2004, 48,223-233.
7. Louis, M., Van Beneden, R., Dehoux, M., Thissen, J. P., Fran-caux, M., Creatine increases IGF-I and myogenic regulatory factor mRNA in C2C12 cells, FEBS Lett. 2004, 557, 243-247.
8. Sabourin, L. A., Rudnicki, M. A., The molecular regulation of myogenesis, Clin. genet. 2000, 57, 16-25.
9. Lowe, D. A., Lund, T., Alway, S. E., Hypertrophy-stimulated myogenic regulatory factor mRNA increases are attenuated in fast muscle of aged quails, Am. J. Physiol. 1998, 275,C155-C162.
10. Braun, T., Bober, E., Buschhausen-Denker, G., Kohtz, S., et al., Differential expression of myogenic determination genes in muscle cells: Possible autoactivation by the Myf gene products, EMBO J. 1989, 8, 3617-3625.
11. Hasty, P., Bradley, A., Morris, J. H., Edmondson, D. G., et al., Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene, Nature 1993, 364, 501-506.
12. Dedieu, S., Mazeres, G., Cottin, P., Brustis, J. J., Involvement of myogenic regulator factors during fusion in the cell line C2C12, Int. J. Dev. Biol. 2002, 46, 235-241.
13. Puri, P. L., Sartorelli, V., Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-tran-scriptional modifications, J. Cell. Physiol. 2000, 185, 155-173.
14. Kislinger, T., Gramolini, A. O., Pan, Y., Rahman, K., et al., Proteome dynamics during C2C12 myoblast differentiation, Mol. Cell. Proteomics 2005, 4, 887-901.
15. Barash, I. A., Bang, M. L., Mathew, L., Greaser, M. L., et al.,Structural and regulatory roles of muscle ankyrin repeat protein family in skeletal muscle, Am. J. Physiol. Cell. Physiol.2007,293, C218-C227.
16. Jacquemin, V., Butler-Browne, G. S., Furling, D., Mouly, V., IL-13 mediates the recruitment of reserve cells for fusion dur-ing IGF-1-induced hypertrophy of human myotubes, J. Cell Sci. 2007, 120, 670-681.
17. Ueyama, T., Zhu, C., Valenzuela, Y. M., Suzow, J. G., Stewart, A. F., Identification of the functional domain in the transcrip-tion factor RTEF-1 that mediates alpha 1-adrenergic signal-ing in hypertrophied cardiac myocytes, J. Biol. Chem. 2000,275,17476-17480.
18. Forcales, S. V., Puri, P. L., Signaling to the chromatin during skeletal myogenesis: Novel targets for pharmacological mod- ulation of gene expression, Semin. Cell. Dev. Biol. 2005, 16,596-611.
19. Langen, R. C., Schols, A. M., Kelders, M. C., Van Der Vel-den, J. L. et al., Tumor necrosis factor-alpha inhibits myogen-esis through redox-dependent and -independent pathways, Am. J. Physiol. Cell. Physiol. 2002, 283, C714-C721.
20. Buck, M., Chojkier, M., Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxi-dants, EMBO J. 1996, 15, 1753-1765.
21. Tidball, J. G., Inflammatory processes in muscle injury and repair, Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, R345-R353.
22. Pizza, F. X., Peterson, J. M., Baas, J. H., Koh, T. J., Neutro-phils contribute to muscle injury and impair its resolution after lengthening contractions in mice, J. Physiol. 2005, 562,899-913.
23. Messina, S., Altavilla, D., Aguennouz, M., Seminara, P., et al., Lipid peroxidation inhibition blunts nuclear factor-kap-paB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice, Am. J. Pathol. 2006,168,918-926.
24. Toscano, A., Messina, S., Campo, G. M., Di Leo, R., et al.,Oxidative stress in myotonic dystrophy type 1, Free Radic. Res. 2005, 39, 771-776.
25. Fulle, S., Protasi, F., Di Tano, G., Pietrangelo, T., et al., The contribution of reactive oxygen species to sarcopenia and muscle ageing, Exp. Gerontol. 2004, 39, 17-24.
26. Wyss, M., Kaddurah-Daouk, R., Creatine and creatinine metabolism, Physiol. Rev. 2000, 80, 1107-1213.
27. Snow, R. J., Murphy, R. M., Creatine and the creatine trans-porter: A review, Mol. Cell. Biochem. 2001, 224, 169-181.
28. Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., Eppen- berger, H. M., Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The phosphocreatine cir-cuit' for cellular energy homeostasis, Biochem. J. 1992, 281,21-40.
29. Wyss, M., Schulze, A., Health implications of creatine: Can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience 2002, 112, 243-260.
30. Schedel, J. M., Tanaka, H., Kiyonaga, A., Shindo, M., Schutz, Y., Acute creatine ingestion in human: Consequences on serum creatine and creatinine concentrations, Life Sci. 1999,65,2463-2470.
31. Hespel, P., Op't Eijnde, B., Van Leemputte, M., Urso, B., et al., Oral creatine supplementation facilitates the rehabilita-tion of disuse atrophy and alters the expression of musclemyogenic factors in humans, J. Physiol. 2001, 536, 625-633.
32. Hultman, E., Soderlund, K., Timmons, J. A., Cederblad, G.,Greenhaff, P. L., Muscle creatine loading in men, J. Appl. Physiol. 1996, 81, 232-237.
33. Olsen, S., Aagaard, P., Kadi, F., Tufekovic, G., et al., Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training, J. Physiol. 2006, 573, 525-534.
34. Tarnopolsky, M. A., Parise, G., Yardley, N. J., Ballantyne, C.S., et al., Creatine-dextrose and protein-dextrose induce similar strength gains during training, Med. Sci. Sports Exerc.2001,33,2044-2052.
35. Gordon, A., Hultman, E., Kaijser, L., Kristjansson, S., et al.,Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance, Cardiovasc. Res. 1995, 30, 413-418.
36. Hansen, M. J., Gualano, R. C., Bozinovski, S., Vlahos, R., Anderson, G. P., Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease), Pharmacol. Ther. 2006, 109, 162-172.
37. Heinanen, K., Nanto-Salonen, K., Komu, M., Erkintalo, M., et al., Creatine corrects muscle 31P spectrum in gyrate atro-phy with hyperornithinaemia, Eur. J. Clin. Invest. 1999, 29,1060-1065.
38. Kuethe, F., Krack, A., Richartz, B. M., Figulla, H. R., Crea- tine supplementation improves muscle strength in patients with congestive heart failure, Die Pharmazie 2006, 61, 218-222.
39. Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., et al., Creatine and cyclocreatine attenuate MPTP neurotoxicity, Exp. Neurol. 1999, 157, 142-149.
40. Mazzini, L., Balzarini, C., Colombo, R., Mora, G., et al., Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: Pre-liminary results, J. Neurol. Sci. 2001, 191, 139-144.
41. Osbakken, M., Ito, K., Zhang, D., Ponomarenko, I., et al., Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart, Cardiology 1992, 80, 184-195.
42. Sipila, I., Rapola, J., Simell, O., Vannas, A., Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina, N. Engl. J. Med. 1981, 304, 867-870.
43. Stout, J. R., Eckerson, J. M., May, E., Coulter, C., Bradley-Popovich, G. E., Effects of resistance exercise and creatine supplementation on myasthenia gravis: A case study, Med. Sci. Sports Exerc. 2001, 33, 869-872.
44. Tarnopolsky, M. A., Mahoney, D. J., Vajsar, J., Rodriguez, C., et al., Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy, Neurology 2004,62,1771-1777.
45. Vorgerd, M., Grehl, T., Jager, M., Muller, K., et al., Creatine therapy in myophosphorylase deficiency (McArdle disease): A placebo-controlled crossover trial, Arch. Neurol. 2000, 57,956-963.
46. Witte, K. K., Clark, A. L., Cleland, J. G., Chronic heart failure and micronutrients, J. Am. Coll. Cardiol. 2001, 37, 1765- 1774.
47. Lawler, J. M., Barnes, W. S., Wu, G., Song, W., Demaree, S., Direct antioxidant properties of creatine, Biochem. Biophys. Res. Commun. 2002, 290, 47-52.
48. Sestili, P., Martinelli, C., Bravi, G., Piccoli, G., et al., Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity, Free Radic. Biol. Med. 2006, 40, 837-849.
49. Lenz, H., Schmidt, M., Welge, V., Schlattner, U., et al., The creatine kinase system in human skin: protective effects of creatine against oxidative and UV damage in vitro and in vivo, J. Invest. Dermatol. 2005, 124, 443-452.
50. Guidi, C., Potenza, L., Sestili, P., Martinelli, C., et al., Differ-ential effect of creatine on oxidatively-injured mitochondrial and nuclear DNA, Biochim. Biophys. Acta 2008, 1780, 16-26.
51. Vina, J., Borras, C., Miquel, J., Theories of ageing, IUBMB life 2007, 59, 249-254.
52. Bender, A., Beckers, J., Schneider, I., Holter, S. M., et al., Creatine improves health and survival of mice, Neurobiol. Aging 2008, 29, 1404-1411.
53. Vilquin, J. T., Myoblast transplantation: Clinical trials and perspectives. Mini-review, Acta Myol. 2005, 24, 119-127.
54. [54] Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 1976, 72, 248- 254.
55. Aebi, H., Catalase in vitro, Meth. Enzymol. 1984, 105, 121- 126.
56. Lawrence, R. A., Burk, R. F., Glutathione peroxidase activity in selenium-deficient rat liver, Biochem. Biophys. Res. Com- mun. 1976, 71, 952-958.
57. Cantoni, O., Sestili, P., Guidarelli, A., Cattabeni, F., Develop- ment and characterization of hydrogen peroxide-resistant Chinese hamster ovary (CHO) cell variants-II. Relationships between non-protein sulfhydryl levels and the induction/ stability of the oxidant-resistant phenotype, Biochem. Phar- macol. 1994, 47, 1258-1261.
58. Sinha, P., Poland, J., Schnolzer, M., Rabilloud, T., A new silver staining apparatus and procedure for MALDI-time of flight analysis of proteins after two-dimensional electropho-resis, Proteomics 2001, 1, 835-840.
59. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 1970, 227, 680-685.
60. Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. U. S.A. 1979, 76, 4350-4354.
61. Ogilvie, M., Yu, X., Nicolas-Metral, V., Pulido, S. M., et al., Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts, J. Biol. Chem. 2000, 275, 39754-39761.
62. Pfaffl, M. W., A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res. 2001, 29, e45.
63. Louis, M., Van Beneden, R., Dehoux, M., Thissen, J. P., Fran-caux, M., Creatine increases IGF-I and myogenic regulatory factor mRNA in C(2)C(12) cells, FEBS Lett. 2004, 557,243-247.
64. Alfieri, R. R., Bonelli, M. A., Cavazzoni, A., Brigotti, M., et al., Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress, J. Physiol. 2006, 576, 391-401.
65. Tarnopolsky, M., Parise, G., Fu, M. H., Brose, A., et al.,Acute and moderate-term creatine monohydrate supplemen-tation does not affect creatine transporter mRNA or protein content in either young or elderly humans, Mol. Cell. Bio-chem. 2003, 244, 159-166.
66. Deldicque, L., Theisen, D., Bertrand, L., Hespel, P., et al.,Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways, Am. J. Phys-iol. Cell. Physiol. 2007, 293, C1263-C1271.
67. Curci, R., Battistelli, M., Burattini, S., D'Emilio, A., et al.,Cell membrane behaviour along skeletal muscle cell in vitro differentiation, Micron 2008, 39, 843-851.
68. Tannu, N. S., Rao, V. K., Chaudhary, R. M., Giorgianni, F., et al., Comparative proteomes of the proliferating C(2)C(12) myoblasts and fully differentiated myotubes reveal the complexity of the skeletal muscle differentiation program, Mol. Cell. Proteomics 2004, 3, 1065-1082.
69. Scholz, A., Hinssen, H., Biphasic pattern of gelsolin expres-sion and variations in gelsolin-actin interactions during myo-genesis, Exp. Cell Res. 1995, 219, 384-391.
70. Ishibashi, J., Perry, R. L., Asakura, A., Rudnicki, M. A.,Myo D induces myogenic differentiation through co operation of its NH2- and COOH-terminal regions, J. Cell. Biol. 2005,171,471-482.
71. Deldicque, L., Theisen, D., Bertrand, L., Hespel, P. J., et al.,Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways, Am. J. Phys- iol. Cell Physiol. 2007, 293, C1263-1271.
72. Caporossi, D., Ciafre, S. A., Pittaluga, M., Savini, I., Farace, M. G., Cellular responses to H(2)O(2) and bleomycin-induced oxidative stress in L6C5 rat myoblasts, Free Radic. Biol. Med. 2003, 35, 1355-1364.
73. Catani, M. V., Savini, I., Duranti, G., Caporossi, D., et al.,Nuclear factor kappaB and activating protein 1 are involved in differentiation-related resistance to oxidative stress in skel-etal muscle cells, Free Radic. Biol. Med. 2004, 37, 1024-1036.
74. Ardite, E., Barbera, J. A., Roca, J., Fernandez-Checa, J. C.,Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation, Am. J. Pathol. 2004, 165, 719-728.
75. Pawlikowska, P., Gajkowska, B., Hocquette, J. F., Orzechow- ski, A., Not only insulin stimulates mitochondriogenesis in muscle cells, but mitochondria are also essential for insulin-mediated myogenesis, Cell Prolif. 2006, 39, 127-145.
76. Rochard, P., Rodier, A., Casas, F., Cassar-Malek, I., et al.,Mitochondrial activity is involved in the regulation of myo-blast differentiation through myogenin expression and activ-ity of myogenic factors, J. Biol. Chem. 2000, 275, 2733-2744.
77. Brosnan, M. E., Edison, E. E., da Silva, R., Brosnan, J. T.,New insights into creatine function and synthesis, Adv. Enzyme Regul. 2007, 47, 252-260.
78. Ducray, A. D., Schlappi, J. A., Qualls, R., Andres, R. H., et al., Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord, J.Neurosci. Res. 2007, 85, 1863-1875.
79. Rodriguez, M. C., MacDonald, J. R., Mahoney, D. J., Parise, G., et al., Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders, Muscle Nerve 2007, 35,235-242.
80. Oliveira, M. S., Furian, A. F., Fighera, M. R., Fiorenza, N. G. et al., The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement, Behav. Brain Res. 2008, 187, 200-204.
81. Savini, I., Catani, M. V., Duranti, G., Ceci, R., et al., Vitamin C homeostasis in skeletal muscle cells, Free Radic. Biol. Med. 2005, 38, 898-907.
82. Luzi, L., Confalonieri, S., Di Fiore, P. P., Pelicci, P. G., Evolution of Shc functions from nematode to human, Curr. Opin. Genet. Dev. 2000, 10, 668-674.
83. Zaccagnini, G., Martelli, F., Magenta, A., Cencioni, C., et al.,p66(ShcA) and oxidative stress modulate myogenic differentiation and skeletal muscle regeneration after hind limb ische-mia, J. Biol. Chem. 2007, 282, 31453-31459.